Regeneron Pharmaceuticals Inc (REGN)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$737.00

Buy

$765.00

arrow-down$-17.40 (-2.28%)

Prices updated at 20 Nov 2024, 00:56 EST

Prices minimum 15 mins delay

Prices in USD

Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

NASDAQ

1.04%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2022	2023
	12,173m	13,117m
	10,613m	11,301m
	4,994m	4,233m
	41.03	32.27
	4,338m	3,954m
	5,260m	4,693m
Sales, General and administrative	2,116m	2,631m
Interest expenses	59m	73m
Provision for income taxes	520m	246m
Operating expenses	5,619m	7,068m
Income before taxes	4,859m	4,199m
Net income available to common shareholders	4,338m	3,954m
	40.51	37.05
Net interest income	101m	423m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	38.22	34.77
Free cash flow per share	36.6018	38.3049
Book value/share	195.6095	227.6076
Debt equity ratio	0.119193	0.104065

Balance sheet

Year chevron-l-regular chevron-r-regular	2022	2023
Current assets	15,884m	19,479m
Current liabilities	3,141m	3,423m
Total capital	24,645m	27,956m
Total debt	2,701m	2,703m
Total equity	22,664m	25,973m
Total non current liabilities	-	-
Loans	1,981m	1,983m
Total assets	29,215m	33,080m
Total liabilities	-	-
Cash and cash equivalents	3,106m	2,730m
Common stock	110m	109m

Cash flow

Year chevron-l-regular chevron-r-regular	2022	2023
Cash at beginning of period	2,898m	3,119m
Cash dividends paid	-	-
	3,398m	3,668m
Investments (gains) losses	-3,785m	-3,185m
	3,119m	2,738m
Net income	-	-
	5,015m	4,594m
	-1,617m	-926m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.